[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367252-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367252-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unraveling-the-genetic-landscape-of-susceptibility-to-multiple-primary-cancers","Unraveling the Genetic Landscape of Susceptibility to Multiple Primary Cancers","","Unraveling the genetic landscape of susceptibility to multiple primary cancers examines how common inherited genetic variation may influence risk beyond hereditary cancer syndromes. Using a cross-ancestry GWAS and TWAS on 10,983 individuals with multiple primary cancers, 84,475 with a single cancer, and 420,944 cancer-free controls, the study identifies six lead variants across five genomic regions and one additional variant versus single cancer. Telomere maintenance and immune dysregulation emerge as central pathways, highlighting shared mechanisms for targeted prevention and intervention strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unraveling-the-genetic-landscape-of-susceptibility-to-multiple-primary-cancers/367252/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unraveling-the-genetic-landscape-of-susceptibility-to-multiple-primary-cancers/367252.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding multiple primary cancers?","Question",{"text":63,"@type":64},"To assess whether common genetic variation contributes to susceptibility to developing multiple primary tumors, beyond known hereditary cancer syndromes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was genetic susceptibility studied in the paper?",{"text":68,"@type":64},"Through a cross-ancestry genome-wide association study (GWAS) and a transcriptome-wide association study (TWAS) using participants from two large-scale studies.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biological pathways are implicated by the study’s findings?",{"text":72,"@type":64},"Telomere maintenance and immune dysregulation are highlighted as central, common pathways influencing susceptibility to multiple cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367252,1790380994,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","ARTICLE  \nUnraveling the genetic landscape of susceptibility to multiple primary cancers  \nPooja Middha, 1 Linda Kachuri,2,3 Jovia L. Nierenberg,4 Rebecca E. Graff,4,5,6 Taylor B. Cavazos,4 Thomas J. Hoffmann,4, 7 Jie Zhang,5 Stacey Alexeeff,5 Laurel Habel,5 Douglas A. Corley,5  \nStephen Van Den Eeden,5 Lawrence H. Kushi,5 Elad Ziv,1,6, 7 Lori C. Sakoda,5,8 and John S. Witte2,3,9, 10,* Summary  \nWith advances in cancer screening and treatment, there is a growing population of cancer survivors who may develop subsequent primary cancers. While hereditary cancer syndromes account for only a portion of multiple cancer cases, we sought to explore the role of common genetic variation in susceptibility to multiple primary tumors. We conducted a cross-ancestry genome-wide association study (GWAS) and transcriptome-wide association study (TWAS) of 10,983 individuals with multiple primary cancers, 84,475 individuals with single cancer, and 420,944 cancer-free controls from two large-scale studies. Our GWAS identiﬁed six lead variants across ﬁve genomic regions that were signiﬁcantly associated (p \u003C 5 3 10􀀁8) with the risk of developing multiple primary tumors (overall and invasive) relative to cancer-free controls (at 3q26, 8q24, 10q24, 11q13.3, and 17p13) . We also found one variant signiﬁcantly associated with multiple cancers when compared with single cancer cases (at 22q13.1) . Multi-tissue TWAS detected associations with genes involved in telomere maintenance in two of these regions (ACTRT3 in 3q26 andSLKandSTN1 in 10q24) and the development of multiple cancers. Additionally, the TWAS also identiﬁed several novel genes associated with multiple cancers, including two immune-related genes, IRF4 and TNFRSF6B. Telomere maintenance and immune dysregulation emerge as central, common pathways inﬂuencing susceptibility to multiple cancers. These ﬁndings underscore the importance of exploring shared mechanisms in carcinogenesis, offering insights for targeted prevention and intervention strategies.  \nIntroduction  \nAdvances in cancer screening, diagnosis, and treatment have led to earlier detection of cancer and increased survival in cancer patients.1,2 Given the substantial worldwide prevalence of cancer and the rising rates of survival, there has been a considerable increase in the number of cancer survivors who face an elevated risk of developing a second primary cancer during their lifetime.3–5 Understanding risk factors for multiple primary cancers can have practical implications for managing patients with multiple cancers and may help prioritize screening strategies among cancer survivors. For patients with a history of cancer and prior anticancer treatments, distinguishing between a newly developed metastasis from the initial cancer and a second malignancy can be challenging and is under-studied.6 Recognizing these scenarios and conducting appropriate investigations is essential for shaping subsequent therapeutic strategies. Furthermore, the presence of multiple primary cancers can impact a patient’s eligibility for enrollment in clinical research protocols, as individuals with a prior cancer history or concurrent secondary malignancies are typically excluded from clinical  \ntrials. Therefore, it is crucial to identify and understand risk factors associated with multiple primary cancers to manage and treat patients effectively.  \nIncreased susceptibility to multiple cancers couldbeattributed to a variety of factors, such as lifestyle factors, environmental exposures, and genetic factors.3,4 Furthermore, treatments such as radiation therapy or chemotherapy, which are often administered for the initial cancer diagnosis, introduce their own set of potential risks associated with the development of subsequent primary cancers.3,4 Additionally, hereditary cancer syndromes, accounting for 1%–2% of all people with cancer diagnoses, are associated with an elevated risk of multiple cancers.6 Some studies have shown that individuals with multip","cbCailAJyaZ4mrcL","https://ap.wps.com/l/cbCailAJyaZ4mrcL","pdf",3608448,16,"English","# Summary\n## Introduction\n## Study rationale and background\n## Genetic contribution to multiple cancers\n# Methods and analyses (as described in summary)","[{\"question\":\"What is the study’s main goal regarding multiple primary cancers?\",\"answer\":\"To assess whether common genetic variation contributes to susceptibility to developing multiple primary tumors, beyond known hereditary cancer syndromes.\"},{\"question\":\"How was genetic susceptibility studied in the paper?\",\"answer\":\"Through a cross-ancestry genome-wide association study (GWAS) and a transcriptome-wide association study (TWAS) using participants from two large-scale studies.\"},{\"question\":\"Which biological pathways are implicated by the study’s findings?\",\"answer\":\"Telomere maintenance and immune dysregulation are highlighted as central, common pathways influencing susceptibility to multiple cancers.\"}]","Unraveling the Genetic Landscape of Susceptibility to Multiple Primary Cancers | PDF",1790169914,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14d4cb3cf608f7aee8eea6edf435ff5d.webp",983,1276,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0c4865b237055cbe2462158603775c1.webp",982,1275,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eca64099d59a87f23289db1f7ca135e9.webp",981,1273,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e55d7b44d47c2574e151d437e9e9961.webp",980,1272]